Journey Medical (DERM) Non Operating Income (2020 - 2026)
Journey Medical (DERM) posted Non Operating Income of -$738000.0 for Q1 2026, up 8.21% on a QoQ basis from -$804000.0 in Q4 2025, and up 1.47% year-over-year from -$727318.4 in Q1 2025.
Journey Medical (DERM) Non Operating Income (2020 - 2026) Analysis & Trends
Journey Medical's Non Operating Income history runs 7 years deep, the most recent figure standing at -$738000.0 for Q1 2026.
- Quarterly Non Operating Income rose 1.47% year-over-year to -$738000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.2 million (down 139.52% YoY) and the FY2025 annual result came in at -$3.2 million, down 242.51% from the prior year.
- Non Operating Income was -$738000.0 for Q1 2026 at Journey Medical, up from -$804000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $504000.0 in Q3 2024 and bottomed at -$860000.0 in Q2 2025.
- A 5-year average of -$498705.9 and a median of -$578000.0 in 2022 frame the typical range for Non Operating Income.
- Peak annual rise in Non Operating Income reached 239.61% in 2024, while the deepest fall reached 849.43% in 2024.
- Journey Medical's Non Operating Income stood at -$634000.0 in 2022, then soared by 113.72% to $87000.0 in 2023, then plunged by 849.43% to -$652000.0 in 2024, then slipped by 23.31% to -$804000.0 in 2025, then grew by 8.21% to -$738000.0 in 2026.
- Business Quant data shows DERM's Non Operating Income at -$738000.0 in Q1 2026, -$804000.0 in Q4 2025, and -$786000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -7.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn | -738,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -738,000.00 |
| Dec 31, 2025 | -804,000.00 |
| Sep 30, 2025 | -786,000.00 |
| Jun 30, 2025 | -860,000.00 |
| Mar 31, 2025 | -749,000.00 |
| Dec 31, 2024 | -652,000.00 |
| Sep 30, 2024 | 504,000.00 |
| Jun 30, 2024 | -434,000.00 |
| Mar 31, 2024 | -352,000.00 |
| Dec 31, 2023 | 87,000.00 |
| Sep 30, 2023 | -361,000.00 |
| Jun 30, 2023 | -710,000.00 |
| Mar 31, 2023 | -575,000.00 |
| Dec 31, 2022 | -634,000.00 |
| Sep 30, 2022 | -578,000.00 |
| Jun 30, 2022 | -450,000.00 |
| Mar 31, 2022 | -386,000.00 |
| Dec 31, 2021 | -4.36 Mn |
| Sep 30, 2021 | -1.38 Mn |
| Jun 30, 2021 | -1.52 Mn |